Compositions for treating muscular dystrophy
US10364431B2 · kind B2 · utility
37Cited by
97References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 24, 2017 |
| Grant date | Jul 30, 2019 |
| Priority date | — |
| Expiry date | May 24, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.